SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-276245
Filing Date
2021-09-17
Accepted
2021-09-17 17:10:10
Documents
13
Period of Report
2021-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d221390d8k.htm   iXBRL 8-K 27750
2 EX-10.1 d221390dex101.htm EX-10.1 200525
  Complete submission text file 0001193125-21-276245.txt   400605

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grts-20210916.xsd EX-101.SCH 2919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20210916_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20210916_pre.xml EX-101.PRE 11878
6 EXTRACTED XBRL INSTANCE DOCUMENT d221390d8k_htm.xml XML 3462
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 211261224
SIC: 2836 Biological Products, (No Diagnostic Substances)